CTIS.eu › Cities › Germany › Magdeburg
Magdeburg
Germany
221 total trials
95 recruiting
2022-501456-28-00
5
2020-07-20
atypical teratoid/rhabdoid tumours (ATRT)
2022-501454-11-00
5
2020-02-05
standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
2023-508302-24-00
4
2019-05-07
Locally Advanced/Metastatic Urothelial Cancer
2023-504201-36-00
10
2018-12-21
Defined by parent protocol. The study will enroll all adult and paedia
2024-512222-28-00
10
2015-06-02
Newly diagnosed with an intracranial or spinal ependymoma (all WHO gra
2025-521067-13-00
5
2026-04-24
Atherosclerotic Cardiovascular Disease (ASCVD)
2025-521912-21-00
4
2026-01-26
Cardiovascular risk reduction in participants with elevated Lp(a)
2025-520521-21-00
5
2025-09-02
Hyperlipidemia
2024-518321-15-00
4
2025-05-30
Asthma
2022-502878-16-00
5
2025-01-23
Acute ischemic strokes with incomplete reperfusion
2024-511881-35-00
5
2024-12-17
Prurigo Nodularis
2023-509301-80-00
5
2024-11-04
Severe hypertriglyceridemia (SHTG)
2023-509302-30-00
5
2024-11-04
Hypertriglyceridemia
2023-508096-36-00
5
2024-10-30
atopic dermatitis
2022-501457-37-00
5
2024-10-28
Myeloid Leukemia in Children with Down Syndrome
2023-509190-23-00
5
2024-09-03
Atherosclerotic Cardiovascular Disease
Elevated lp(a)
2023-506906-38-00
5
2024-05-23
Follicular Lymphoma
2022-502518-98-00
5
2024-04-26
nonsegmental vitiligo
2023-503422-39-00
5
2023-10-20
Hepatocellular Carcinoma (HCC)
2022-501343-33-00
5
2023-10-18
Biochemically recurrent prostate cancer
2022-502012-37-00
5
2023-10-06
Advanced Hepatocellular Carcinoma
2023-504215-32-00
9
2023-09-28
Overweight and obesity
2023-504028-24-00
5
2023-09-22
Large B-Cell Lymphoma
Showing 97–120 of 221 trials